Wednesday March 20, 2019
Home India Family member...

Family members blame Kolkata private hospital for patient’s death due to Negligence and Wrong Treatment

Media Superspecialty Clinic in Kolkata, Wikimedia

Kolkata, March 13, 2017: Family members of a patient on Monday lodged a police complaint, blaming a private hospital in the city of negligence and wrong treatment for his death.

The wife of Sunil Pandey, who died at the Medica Superspecialty Hospital on Monday morning, alleged that he died due to “wrong treatment and negligence” on the part of the hospital and lodged a police complaint.

“We have received a complaint from the wife of the deceased about the patient’s sudden death at the hospital. We will look into the issue once we get the autopsy report,” an officer from East Jadavpur Police Station said.

Pandey, who was admitted with chest pain, got admitted to the hospital on March 6 and underwent multiple surgeries, including a leg amputation in the last few days. On Monday morning, doctors at the hospital declared him dead.

“He did not have blood sugar, high blood pressure or any major health issues. We took him to the hospital as he felt chest pain, but his condition drastically deteriorated after the surgery,” the widow alleged.

“The hospital finished him by doing wrong treatment. I have lodged a police complaint against them for taking him away from us. I want justice in this case so that no one else has to go through the same in future,” she said.

According to the patient’s side, Pandey underwent cardiac surgery which the hospital claimed to be successful. However, the doctors amputated one of his legs as there was a major blood clot.

“Why did he have the blood clot in his leg if the cardiac operation was successful? Why could not they save him in spite of the leg amputation? The hospital is asking for 48 hours to produce the case history details. This clearly shows there is an issue of negligence at their end,” a friend of the deceased said.

The hospital authorities, however, rubbished the allegations and said proper course of action was followed during the patient’s treatment.

“The incident is unfortunate, but I am certain that the doctors here followed a proper course of action that was required for the patient’s treatment. The condition of the patient was critical and we kept the patient party updated on his condition at every point,” a doctor from the hospital said.

“We had to go through the leg amputation as a standard treatment procedure as the blood supply to that leg had completely stopped due to massive blood clots in the vein. The unresponsive body part had to be removed to stop the entire body from rotting,” he added. (IANS)

Next Story

Researchers Develop Novel Treatment to Treat Diabetes, Multiple Sclerosis

However, in people with autoimmune disease, these cells somehow escape the checkpoint and the immune system remains in a state of alert, attacking body cells

Representational image. Pixabay

Researchers have developed a novel and safe treatment for autoimmune diseases including Type-1 diabetes and multiple sclerosis (MS) that arise when the body’s immune cells attack itself.

Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections.

The new approach, by researchers from the University of Utah in the US, targets the misfunctioning immune cells while leaving the normal immune cells in place.

In the study, published in the journal Nature Biomedical Engineering, the team engineered a protein molecule to deplete the misfunctioning PD-1-expressing cells from the body while leaving normal immune cells in place.

“We wanted to target PD-1-expressing cells. Using this method, we may avoid long-term immune deficiency caused by common treatments for autoimmune disease,” said lead author Peng Zhao, from the varsity.

When tested in a mouse model mimicking Type-1 diabetes, the treatment delayed the onset of diabetes.

“We are really taking treatment for autoimmune disease in a new direction,” said Mingnan Chen, Assistant Professor at the varsity.

Representational image. Pixabay

“To make similar therapeutics for people, we would need to find the anti-human PD-1 antibody, like the anti-mouse PD-1 antibody.

“If we can generate the human version of therapeutics, I think we could make a huge impact in treating autoimmune disease,” Chen said.

In addition, the treatment was also applied to a mouse MS model.

Also Read- Mouth Watering Biryani Ordered Online Has Become New Normal for Millennials

Besides halting the progression of paralysis, the treatment also restored the mice’s ability to walk.

In a normal functioning immune system, the PD-1-expressing cells, including immune cells, contain a mechanism that prevents the cycle from attacking itself.

However, in people with autoimmune disease, these cells somehow escape the checkpoint and the immune system remains in a state of alert, attacking body cells. (IANS)